Antibody Drug Conjugate Market: How Is the Antibody Drug Conjugate...

added blog Health

2026-06-02 09:55:16

Antibody Drug Conjugate Market: How Is the Antibody Drug Conjugate Market Responding to Breast Cancer and Hematologic Malignancy Treatments?

The Antibody Drug Conjugate Market is responding to breast cancer and hematologic malignancy treatments by providing approved ADCs that have become standard-of-care for HER2-positive breast cancer, triple-negative breast cancer, and various lymphomas. These indications represent the largest commercial opportunities for ADCs. One of the main success stories is trastuzumab emtansine...

0 Comments 0 Shares 0 Reviews